The transfected CD20low B cell population showed a similar surface receptor expression profile for the IgM-BCR, CD19, and CD22 as already detected for CD20KO-N Ramos cells and under RTX treatment in RA patients as well. This evidence concerns the gene CD22 and rheumatoid arthritis.